Fenofast

Fenofast

fenofibrate

Manufacturer:

XL Lab

Distributor:

Meedpharma

Marketer:

Ambica
Concise Prescribing Info
Contents
Fenofibrate
Indications/Uses
Reduction of LDL-cholesterol, total cholesterol, triglycerides, apolipoprotein B & to increase HDL-cholesterol. Management of hyperlipidemias including type IIa, IIb, III, IV & V hyperlipoproteinemias.
Dosage/Direction for Use
Administration
Should be taken with food.
Contraindications
Hypersensitivity. Renal impairment (CrCl <15 mL/min unless patient is on dialysis).
Special Precautions
Severe hepatic impairment or significant liver disease, gallstones or gallbladder disorders or hypoalbuminemic states eg, nephrotic syndrome. Renal impairment. Do not use in pregnancy & lactation.
Adverse Reactions
GI disturbances including anorexia, nausea & gastric discomfort.
Drug Interactions
May displace other drugs from protein-binding sites. Changes in activity of CYP3A4 isoenzymes. May enhance the effects of anticoagulants. May displace from plasma proteins of other drugs including tolbutamide & other sulfonylurea antidiabetics, phenytoin & furosemide. May alter glucose tolerance w/ antidiabetic drugs. Increased risk of myopathy w/ statins. Nephrotoxicity associated w/ increased ciclosporin conc. Cholestasis w/ raloxifene.
ATC Classification
C10AB05 - fenofibrate ; Belongs to the class of fibrates. Used in the treatment of hyperlipidemia.
Presentation/Packing
Form
Fenofast cap 200 mg
Packing/Price
50's
Register or sign in to continue
Asia's one-stop resource for medical news, clinical reference and education
Sign up for free
Already a member? Sign in